Company · CIK 0001235007 · SIC 2834 — Pharmaceutical Preparations
ENDOCYTE INC · ECYT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2016 AForm 4 → | Aug 22, 4:23 pm EDT | Beth TaylorVP Finance & Chief Acctg Offcr | 3,750 | — | — | 21,283 | — | plan? |
| Jul 27, 2016 MForm 4 → | Jul 28, 4:27 pm EDT | Keith E BrauerDirector | 10,471 | $1.91 | $20,000 | 14,971 | — | plan? |
| Jun 24, 2016 FForm 4 → | Jun 28, 5:07 pm EDT | P Ron EllisOther | 13,528 | $3.68 | $49,783 | 320,040 | — | plan? |
| Jun 16, 2016 AForm 4 → | Jun 20, 5:26 pm EDT | Michael A. ShermanPresident, CEO and CFO, Director | 10,000 | — | — | 136,360 | — | plan? |
| May 10, 2016 PForm 4 → | May 12, 4:07 pm EDT | Philip S LowChief Science Officer, Director | 11,375 | $3.52 | $40,040 | 217,981 | +5.51% | plan? |
| May 10, 2016 GForm 4 → | May 12, 4:07 pm EDT | Philip S LowChief Science Officer, Director | 11,566 | — | — | 206,606 | — | plan? |
| May 5, 2016 AForm 4 → | May 6, 4:48 pm EDT | Lesley RussellDirector | 2,250 | — | — | 4,500 | — | plan? |
| May 5, 2016 AForm 4 → | May 6, 4:47 pm EDT | Fred A MiddletonDirector | 2,250 | — | — | 203,249 | — | plan? |
| May 5, 2016 AForm 4 → | May 6, 4:47 pm EDT | Peter D MeldrumDirector | 2,250 | — | — | 4,500 | — | plan? |
| May 5, 2016 AForm 4 → | May 6, 4:46 pm EDT | Marc D KozinDirector | 2,250 | — | — | 4,500 | — | plan? |
| May 5, 2016 AForm 4 → | May 6, 4:46 pm EDT | Ann HanhamDirector | 2,250 | — | — | 4,500 | — | plan? |
| May 5, 2016 AForm 4 → | May 6, 4:45 pm EDT | Colin GoddardDirector | 2,250 | — | — | 4,500 | — | plan? |
| May 5, 2016 AForm 4 → | May 6, 4:45 pm EDT | Keith E BrauerDirector | 2,250 | — | — | 4,500 | — | plan? |
| May 5, 2016 AForm 4 → | May 6, 4:44 pm EDT | John C AplinDirector | 2,250 | — | — | 25,563 | — | plan? |
| Feb 17, 2016 MForm 4 → | Feb 18, 4:30 pm EST | Christopher P LeamonVice President of Research | 13,089 | $1.91 | $25,000 | 61,548 | — | plan? |
| Feb 4, 2016 AForm 4 → | Feb 8, 8:51 pm EST | Katherine ParkerVP of Human Resources | 6,250 | — | — | 17,608 | — | plan? |
| Feb 4, 2016 AFForm 4 → | Feb 8, 8:49 pm EST | Beth TaylorCorporate Controller | 4,275 | $3.02 | $1,586 | 16,482 | — | plan? |
| Feb 4, 2016 AFForm 4 → | Feb 8, 8:49 pm EST | Michael A. ShermanCOO and CFO | 16,840 | $3.13 | $7,728 | 124,972 | — | plan? |
| Feb 4, 2016 AFForm 4 → | Feb 8, 8:48 pm EST | Philip S LowChief Science Officer, Director | 10,526 | $3.12 | $5,536 | 218,172 | — | plan? |
| Feb 4, 2016 AFForm 4 → | Feb 8, 8:48 pm EST | Christopher P LeamonVice President of Research | 10,526 | $3.12 | $5,536 | 48,459 | — | plan? |
| Feb 4, 2016 AFForm 4 → | Feb 8, 8:48 pm EST | Scot HarperVP of CLINICAL OPERATIONS | 10,522 | $3.12 | $5,524 | 22,535 | — | plan? |
| Feb 4, 2016 AFForm 4 → | Feb 8, 8:47 pm EST | P Ron EllisPresident and CEO, Director | 32,280 | $3.12 | $16,854 | 330,951 | — | plan? |
| Feb 4, 2016 AFForm 4 → | Feb 8, 8:47 pm EST | Michael A. BrinkleyVP OF QUALITY | 6,198 | $3.10 | $3,717 | 14,933 | — | plan? |
| Feb 4, 2016 AForm 4 → | Feb 8, 8:47 pm EST | Alison A. ArmourChief Medical Officer | 10,000 | — | — | 30,000 | — | plan? |
| Jan 15, 2016 PForm 4 → | Jan 20, 4:30 pm EST | Fred A MiddletonDirector | 30,000 | $2.80 | $83,900 | 200,999 | +17.5% | plan? |
| Dec 24, 2015 MForm 4 → | Dec 28, 4:00 pm EST | Philip S LowChief Science Officer, Director | 13,089 | $1.91 | $25,000 | 211,198 | — | plan? |
| Jul 31, 2015 AForm 4 → | Aug 4, 7:15 pm EDT | Alison A. ArmourChief Medical Officer | 20,000 | — | — | 20,000 | — | plan? |
| May 14, 2015 AForm 4 → | May 18, 4:36 pm EDT | Lesley RussellDirector | 2,250 | — | — | 2,250 | — | plan? |
| May 14, 2015 AForm 4 → | May 18, 4:34 pm EDT | Fred A MiddletonDirector | 2,250 | — | — | 170,999 | — | plan? |
| May 14, 2015 AForm 4 → | May 18, 4:34 pm EDT | Ann HanhamDirector | 2,250 | — | — | 2,250 | — | plan? |
| May 14, 2015 AForm 4 → | May 18, 4:32 pm EDT | Colin GoddardDirector | 2,250 | — | — | 2,250 | — | plan? |
| May 14, 2015 AForm 4 → | May 18, 4:32 pm EDT | Peter D MeldrumDirector | 2,250 | — | — | 2,250 | — | plan? |
| May 14, 2015 AForm 4 → | May 18, 4:32 pm EDT | Keith E BrauerDirector | 2,250 | — | — | 2,250 | — | plan? |
| May 14, 2015 AForm 4 → | May 18, 4:30 pm EDT | John C AplinDirector | 2,250 | — | — | 23,313 | — | plan? |
| May 14, 2015 AForm 4 → | May 18, 4:30 pm EDT | Marc D KozinDirector | 2,250 | — | — | 2,250 | — | plan? |
| Mar 3, 2015 SForm 4 → | Mar 5, 4:30 pm EST | Binh NguyenVP of Medical Affairs | 29,883 | $5.79 | $172,987 | 28,359 | −51.3% | plan? |
| Mar 3, 2015 MForm 4 → | Mar 5, 4:30 pm EST | Binh NguyenVP of Medical Affairs | 40,000 | $3.55 | $142,000 | 58,242 | — | plan? |
| Feb 10, 2015 MForm 4 → | Feb 26, 6:32 pm EST | Philip S LowChief Science Officer, Director | 544 | $1.91 | $1,039 | 198,109 | — | plan? late |
| Feb 10, 2015 MForm 4 → | Feb 26, 6:31 pm EST | Christopher P LeamonVice President of Research | 13,089 | $1.91 | $25,000 | 39,855 | — | plan? late |
| Feb 6, 2015 MForm 4 → | Feb 26, 6:30 pm EST | P Ron EllisPresident and CEO, Director | 52,356 | $5.21 | $272,775 | 305,196 | — | plan? late |
| Feb 4, 2015 AFForm 4 → | Feb 6, 8:02 pm EST | Beth TaylorCorporate Controller | 5,025 | $5.14 | $2,699 | 11,627 | — | plan? |
| Feb 4, 2015 AFForm 4 → | Feb 6, 8:02 pm EST | Michael A. ShermanCOO and CFO | 15,068 | $5.14 | $3,562 | 110,909 | — | plan? |
| Feb 4, 2015 AFForm 4 → | Feb 6, 8:02 pm EST | Binh NguyenVP of Medical Affairs | 9,458 | $5.14 | $3,639 | 18,242 | — | plan? |
| Feb 4, 2015 AFForm 4 → | Feb 6, 8:01 pm EST | Christopher P LeamonVice President of Research | 9,445 | $5.14 | $3,572 | 26,766 | — | plan? |
| Feb 4, 2015 AFForm 4 → | Feb 6, 8:01 pm EST | Scot HarperVP of CLINICAL OPERATIONS | 9,443 | $5.14 | $3,562 | 15,557 | — | plan? |
| Feb 4, 2015 AForm 4 → | Feb 6, 8:00 pm EST | P Ron EllisPresident and CEO, Director | 26,875 | — | — | 252,840 | — | plan? |
| Feb 4, 2015 AFForm 4 → | Feb 6, 8:00 pm EST | Michael A. BrinkleyVP OF QUALITY | 5,579 | $5.14 | $2,976 | 10,936 | — | plan? |
| Mar 13, 2014 AGForm 4 → | Feb 6, 2015, 8:01 pm EST | Philip S LowChief Science Officer, Director | 22,274 | — | — | 193,318 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2015 AForm 4 → | Feb 6, 8:01 pm EST | Christopher P LeamonVice President of Research | 52,500 | — | — | 52,500 | — | |
| Feb 4, 2015 AForm 4 → | Feb 6, 8:01 pm EST | Scot HarperVP of CLINICAL OPERATIONS | 52,500 | — | — | 52,500 | — | |
| Feb 4, 2015 AForm 4 → | Feb 6, 8:00 pm EST | P Ron EllisPresident and CEO, Director | 161,250 | — | — | 161,250 | — | |
| Feb 4, 2015 AForm 4 → | Feb 6, 8:00 pm EST | Michael A. BrinkleyVP OF QUALITY | 30,000 | — | — | 30,000 | — |